Metabolic Syndrome in Thyroid Disease.

Area of Science:

• Endocrinology
• Metabolic Disorders
• Cardiovascular Health

Background:

• Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors including abdominal obesity, hyperglycemia, low HDL cholesterol, elevated triglycerides, and hypertension.
• MetS is a prevalent endocrine disorder, exacerbated by rising global obesity rates.
• Emerging evidence suggests a significant role for thyroid hormones in modulating MetS components.

Purpose of the Study:

• To review and synthesize the current understanding of the pathophysiological interactions between thyroid hormone status and metabolic syndrome.
• To consolidate knowledge on how thyroid hormones influence key MetS risk factors.

Main Methods:

• Comprehensive literature search of PubMed using keywords related to thyroid hormones and metabolic syndrome components.
• Inclusion of seminal papers and a focus on research published after 2000.

Main Results:

• Thyroid hormones demonstrably affect multiple facets of metabolic syndrome.
• The review details the specific impacts of thyroid hormone status on obesity, dyslipidemia, hyperglycemia, and hypertension.

Conclusions:

• Thyroid hormone status is a critical factor in the development and management of metabolic syndrome.
• Further research into the thyroid-MetS axis may reveal novel therapeutic targets.